https://cantileverinvestors.com/ 2022-05-28 https://cantileverinvestors.com/our-team 2026-01-11 https://cantileverinvestors.com/our-process 2022-01-09 https://cantileverinvestors.com/our-process/consensus 2022-01-04 https://cantileverinvestors.com/our-process/due-diligence 2022-01-04 https://cantileverinvestors.com/our-process/real-world-solution 2022-01-04 https://cantileverinvestors.com/our-process/roi 2022-01-04 https://cantileverinvestors.com/our-process/special-sauce 2022-01-04 https://cantileverinvestors.com/our-process/team 2022-01-04 https://cantileverinvestors.com/portfolio 2022-05-28 https://cantileverinvestors.com/business-partners 2022-08-18 https://cantileverinvestors.com/contact 2021-12-30 https://cantileverinvestors.com/congratulations-to-pathware 2021-12-14 https://cantileverinvestors.com/novolux-awarded-up-and-coming-prize 2021-12-14 https://cantileverinvestors.com/bios/steve-tokarz 2022-01-19 https://cantileverinvestors.com/bios/michael-mortlock 2021-12-15 https://cantileverinvestors.com/bios/michelle-tokarz 2021-12-15 https://cantileverinvestors.com/bios/john-stinson 2021-12-17 https://cantileverinvestors.com/bios/lloyd-doigan 2021-12-15 https://cantileverinvestors.com/bios/mark-sellers 2022-01-04 https://cantileverinvestors.com/bios/mark-smith 2021-12-15 https://cantileverinvestors.com/bios/jack-ahrens 2021-12-17 https://cantileverinvestors.com/bios/george-ehlert 2023-12-20 https://cantileverinvestors.com/bios/mark-ehlert 2023-12-16 https://cantileverinvestors.com/bios/john-freshley 2023-12-18 https://cantileverinvestors.com/bios/keith-cromack 2023-12-16 https://cantileverinvestors.com/bios/don-verlee 2023-12-16 https://cantileverinvestors.com/bios/john-finch 2023-12-18 https://cantileverinvestors.com/portfolio-companies/akadeum-life-sciences-inc 2022-05-28 https://cantileverinvestors.com/portfolio-companies/stabilux-biosciences-inc 2022-05-28 https://cantileverinvestors.com/portfolio-companies/toma-biosciences 2022-05-28 https://cantileverinvestors.com/portfolio-companies/pathware-inc 2022-05-28 https://cantileverinvestors.com/portfolio-companies/kineta-immuno-oncology-llc 2022-05-28 https://cantileverinvestors.com/portfolio-companies/kineta-inc-drug-discovery 2022-05-28 https://cantileverinvestors.com/portfolio-companies/acurx-pharmaceuticals-llc 2022-05-28 https://cantileverinvestors.com/portfolio-companies/acurastem-inc 2022-05-28 https://cantileverinvestors.com/portfolio-companies/brio-device-llc 2021-12-14 https://cantileverinvestors.com/portfolio-companies/attune-medical 2021-12-14 https://cantileverinvestors.com/portfolio-companies/spinal-simplicity-llc 2021-12-14 https://cantileverinvestors.com/portfolio-companies/light-line-medical-inc 2021-12-14 https://cantileverinvestors.com/portfolio-companies/hotel-communications-network-inc 2021-12-14 https://cantileverinvestors.com/portfolio-companies/zive-inc 2021-12-14 https://cantileverinvestors.com/portfolio-companies/dynamo-metrics 2021-12-14 https://cantileverinvestors.com/portfolio-companies/inreality-llc 2021-12-14 https://cantileverinvestors.com/portfolio-companies/rvelocity-inc 2021-12-14 https://cantileverinvestors.com/portfolio-companies/massvr-llc 2021-12-14 https://cantileverinvestors.com/portfolio-companies/carmell-therapeutics 2021-12-14 https://cantileverinvestors.com/portfolio-companies/kyto-technology 2021-12-14 https://cantileverinvestors.com/portfolio-companies/orion-biotechnology 2021-12-14 https://cantileverinvestors.com/portfolio-companies/peptinovo-biopharma 2021-12-14 https://cantileverinvestors.com/portfolio-companies/xenocor 2021-12-14 https://cantileverinvestors.com/news-ii/novolux-awarded-up-and-coming 2021-12-14 https://cantileverinvestors.com/news-ii/light-line-medical-recognized-as-most-valued 2021-12-14 https://cantileverinvestors.com/news-ii/acurx-announces-all-patients-demonstrated-clinical 2021-12-14 https://cantileverinvestors.com/news-ii/new-boost-for-high-brightness-dyes-research 2021-12-14 https://cantileverinvestors.com/news-ii/new-boost-for-high-brightness-dyes 2021-12-14 https://cantileverinvestors.com/news-ii/congrats-to-pathware 2021-12-14 https://cantileverinvestors.com/news-ii/wmu-born-smart-helmet-technology-earns-michigan 2021-12-14 https://cantileverinvestors.com/news-ii/stabilux-biosciences-receives-650-000-in-funding 2021-12-14